Has low-dose atropine hit a snag in its journey to FDA approval for myopia control? A new study casts doubt on its effectiveness vs. placebo, but there might be more than meets the eye. Join myopia expert Dr. Chen-Hsin Sun of Singapore’s prestigious National University Hospital as he talks about the results, how they can be interpreted, and where to go from here. https://lnkd.in/ebcKzU3s #COOKIEmagazine #myopiacontrol #eyedrops
